Park K, Kwon H, Jeong E, Koh H, Lim J
Curr Issues Mol Biol. 2024; 46(9):9555-9564.
PMID: 39329919
PMC: 11430039.
DOI: 10.3390/cimb46090567.
Zheng T, Jiang T, Ma H, Zhu Y, Wang M
Mol Neurobiol. 2024; 61(10):7930-7949.
PMID: 38441860
DOI: 10.1007/s12035-024-04039-1.
Liu B, San L, Guo H, Zhu K, Zhang N, Yang J
Int J Mol Sci. 2023; 24(21).
PMID: 37958869
PMC: 10648848.
DOI: 10.3390/ijms242115886.
Kucukdisli M, Bel-Abed H, Cirillo D, Lo W, Efrem N, Horatscheck A
J Med Chem. 2023; 66(20):14278-14302.
PMID: 37819647
PMC: 11151210.
DOI: 10.1021/acs.jmedchem.3c01319.
Heng E, Maffucci T
Curr Top Microbiol Immunol. 2022; 436:51-68.
PMID: 36243839
DOI: 10.1007/978-3-031-06566-8_2.
The PI3K/AKT signalling pathway in inflammation, cell death and glial scar formation after traumatic spinal cord injury: Mechanisms and therapeutic opportunities.
He X, Li Y, Deng B, Lin A, Zhang G, Ma M
Cell Prolif. 2022; 55(9):e13275.
PMID: 35754255
PMC: 9436900.
DOI: 10.1111/cpr.13275.
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells.
Caglioti C, Palazzetti F, Monarca L, Lobello R, Ceccarini M, Iannitti R
Front Physiol. 2022; 12:790922.
PMID: 35069252
PMC: 8782274.
DOI: 10.3389/fphys.2021.790922.
Calcium-Prolactin Secretion Coupling in Rat Pituitary Lactotrophs Is Controlled by PI4-Kinase Alpha.
Kucka M, Gonzalez-Iglesias A, Tomic M, Previde R, Smiljanic K, Sokanovic S
Front Endocrinol (Lausanne). 2022; 12:790441.
PMID: 35058881
PMC: 8764672.
DOI: 10.3389/fendo.2021.790441.
Role of PI3K/Akt signaling pathway in cardiac fibrosis.
Qin W, Cao L, Massey I
Mol Cell Biochem. 2021; 476(11):4045-4059.
PMID: 34244974
DOI: 10.1007/s11010-021-04219-w.
Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling.
Maffucci T, Falasca M
Int J Mol Sci. 2020; 21(19).
PMID: 33003448
PMC: 7582811.
DOI: 10.3390/ijms21197198.
Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth.
Cisse O, Quraishi M, Gulluni F, Guffanti F, Mavrommati I, Suthanthirakumaran M
J Exp Clin Cancer Res. 2019; 38(1):472.
PMID: 31752944
PMC: 6873561.
DOI: 10.1186/s13046-019-1472-9.
Akt-ing Up Just About Everywhere: Compartment-Specific Akt Activation and Function in Receptor Tyrosine Kinase Signaling.
Sugiyama M, Fairn G, Antonescu C
Front Cell Dev Biol. 2019; 7:70.
PMID: 31131274
PMC: 6509475.
DOI: 10.3389/fcell.2019.00070.
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review).
Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q
Mol Med Rep. 2018; 19(2):783-791.
PMID: 30535469
PMC: 6323245.
DOI: 10.3892/mmr.2018.9713.
Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B, Samarina N, Gramolelli S, Ruckert J, Gerold G, Pich A
J Virol. 2018; 92(17).
PMID: 29950425
PMC: 6096797.
DOI: 10.1128/JVI.00544-18.
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
Murthy D, Attri K, Singh P
Front Physiol. 2018; 9:335.
PMID: 29670543
PMC: 5893816.
DOI: 10.3389/fphys.2018.00335.
Phosphoinositide 3-Kinase-Dependent Signalling Pathways in Cutaneous Squamous Cell Carcinomas.
Janus J, OShaughnessy R, Harwood C, Maffucci T
Cancers (Basel). 2017; 9(7).
PMID: 28696382
PMC: 5532622.
DOI: 10.3390/cancers9070086.
PI3K signaling in Leishmania infections.
Kima P
Cell Immunol. 2016; 309:19-22.
PMID: 27622385
PMC: 5127740.
DOI: 10.1016/j.cellimm.2016.09.004.
Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
Mavrommati I, Cisse O, Falasca M, Maffucci T
Sci Rep. 2016; 6:23277.
PMID: 26983806
PMC: 4794650.
DOI: 10.1038/srep23277.
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Chikh A, Ferro R, Abbott J, Pineiro R, Buus R, Iezzi M
Oncotarget. 2016; 7(14):18325-45.
PMID: 26934321
PMC: 4951291.
DOI: 10.18632/oncotarget.7761.
Specificity of Collybistin-Phosphoinositide Interactions: IMPACT OF THE INDIVIDUAL PROTEIN DOMAINS.
Ludolphs M, Schneeberger D, Soykan T, Schafer J, Papadopoulos T, Brose N
J Biol Chem. 2015; 291(1):244-54.
PMID: 26546675
PMC: 4697159.
DOI: 10.1074/jbc.M115.673400.